Based on karyotype complexity, variant CYP2B6 genotypes presented a borderline significant higher incidence in s-AML patients with complex karyotypes (χ2 = 5.69, df = 2, p = 0.056; Table S3 in File S1). This evidence concerns the gene CYP2B6 and acute myeloid leukemia.